Article PDF
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
In the last 3 years, Helen Reddel has received research grants from GlaxoSmithKline (GSK), has participated on advisory boards for AstraZeneca (AZ), GSK and Novartis, has provided consulting for Biota, GSK and Novartis, and has spoken at symposia funded by AZ, Boehringer Ingelheim, Getz, GSK and Merck
Rights and permissions
About this article
Cite this article
Reddel, H. Action needed on asthma plans. Prim Care Respir J 20, 116–117 (2011). https://doi.org/10.4104/pcrj.2011.00051
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4104/pcrj.2011.00051